What is NDC 0270-1410?

0270-1410 is the product NDC for Cystografin Dilute (diatrizoate meglumine), Diatrizoate meglumine 180 mg/mL injection, solution, listed with the FDA by BRACCO DIAGNOSTICS INC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Cystografin Dilute (Diatrizoate meglumine).

BRACCO DIAGNOSTICS INC, NDC labeler code 0270. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cystografin Dilute?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cystografin Dilute NDC 0270-1410 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0270-1410Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00270-1410Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0270-1410-30	0027014103000270141030	10 BOTTLE in 1 PACKAGE (0270-1410-30) / 300 mL in 1 BOTTLEMarketed from Nov 9, 1982

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cystografin Dilute
Generic name (nonproprietary): diatrizoate meglumine
Active ingredients: Diatrizoate meglumine — 180 mg/mL
Dosage form: Injection, Solution
Route: Intravesical
Labeler: BRACCO DIAGNOSTICS INCNDC labeler code 0270
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 010040
Marketing start: Nov 9, 1982
Listing expires: Dec 31, 2027
Other FDA classes: X-Ray Contrast Activity (Mechanism)
Identifiers: Product ID 0270-1410_2f934688-ef2a-f0c7-0551-629d917b8358SPL ID 2f934688-ef2a-f0c7-0551-629d917b8358SPL set ID e56882fa-4a30-43b1-bb6b-f7d4a4101c4eUNII 3X9MR4N98U
Pharmacologic class: Radiographic Contrast Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400270141030 followed by a unit qualifier and the quantity

Package 00270-1410-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 23, 2025.

Indications (excerpt from the label)

INDICATION Cystografin Dilute is indicated for retrograde cystourethrography.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0270-1410

What is NDC 0270-1410?: 0270-1410 is the product NDC for Cystografin Dilute (diatrizoate meglumine), Diatrizoate meglumine 180 mg/mL injection, solution, listed with the FDA by BRACCO DIAGNOSTICS INC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cystografin Dilute (Diatrizoate meglumine).
What is the active ingredient?: Diatrizoate meglumine.
Who is the labeler?: BRACCO DIAGNOSTICS INC, NDC labeler code 0270. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cystografin Dilute?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 010040

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 010040
Product	Strength	Form · route	Labeler	Product NDC
Cystografindiatrizoate meglumine	Diatrizoate meglumine 300 mg/mL	Injection, SolutionIntravenous	BRACCO DIAGNOSTICS INC	0270-0149

Cystografin Dilute (Diatrizoate meglumine) NDC 0270-1410